Preview Mode Links will not work in preview mode

Eagle's Eye View: Your Weekly CV Update From ACC.org


Jan 11, 2023

In this week’s View, Dr. Eagle discuses heart failure drug treatment - inertia, titration and discontinuation as analyzed in EVOLUTION HF, a multinational observational study, then looks at Non-Obstructive Coronary Arteries (INOCA), and insights gained from the ISCHEMIA Trial. Finally, Dr. Eagle explores findings regarding exercise volume versus intensity and the progression of coronary atherosclerosis in middle-aged and older athletes from the MARC-2 Study. 

Subscribe to Eagle’s Eye View